Contemporary Management for Gallbladder Cancer: From Diagnosis to Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (15 October 2024) | Viewed by 919
Special Issue Editor
Interests: biliary cancer; liver cancer; pancreatic cancer; liquid biopsy
Special Issue Information
Dear Colleagues,
Gallbladder cancer (GBCA) is a rare, but aggressive disease with a propensity for early invasion of the adjacent organs and dissemination to lymph nodes and peritoneal surfaces. As patients with GBCA often remain asymptomatic until the advanced stage, it has historically been considered an incurable disease with dismal prognosis, and the clinical attitude towards GBCA has been characterized by pessimism in the past. In recent decades, however, chemotherapy for biliary cancer has evolved and more effective regimens are more commonly used in the management of GBCA. Furthermore, along with recent increased use of computed tomography or abdominal ultrasound in general practice, the number of patients with GBCA incidentally discovered at the early stage has been increasing. Thus, in this Special Issue, we call for papers on the contemporary management for patients with GBCA and its outcomes. The scope includes modern multidisciplinary approaches for advanced GBCA, strategies for early GBCA, and other translational research for novel diagnostic/therapeutic strategies.
Dr. Hiromichi Ito
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gallbladder cancer
- radical cholecystectomy
- adjuvant chemotherapy
- neoadjuvant therapy
- incidental gallbladder cancer
- multidisciplinary management
- preoperative staging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
